Navigation Links
Perrigo Confirms Filing for Generic Version of Gynazole-1® Cream and Announcement of Patent Infringement Lawsuit by KV Pharma
Date:7/30/2010

ALLEGAN, Mich., July 30 /PRNewswire-FirstCall/ -- Perrigo Company (Nasdaq: PRGO;TASE) announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug Application (ANDA) for butoconazole nitrate vaginal cream, 2% and that is has notified KV Pharmaceutical Company, the owner of the New Drug Application (NDA) as well as FemmePharma, the listed owner of the patent, of its ANDA filing. KV is a licensee under the patent.  Perrigo believes it is first-to-file on this product.

On July 29, 2010, KV Pharmaceutical Company filed suit in the United States District Court for the District of Delaware, alleging patent infringement to prevent Perrigo from proceeding with the commercialization of this product. This action formally initiates the process under the Hatch-Waxman Act.  The suit also named FemmePharma as a defendant as it had not agreed to join KV as a plaintiff in the suit.

Gynazole·1® (butoconazole nitrate) vaginal cream, 2% is indicated for the local treatment of vulvovaginal candidiasis (infections cause by Candida).  Prior to its being discontinued in January 2009 due to manufacturing issues at KV, its annual sales were approximately $28 million annually, as measured by Wolters Kluwer Health.

Perrigo's Chairman and CEO Joseph C. Papa stated, "This filing is another example of our investment in new products and expansion of our product portfolio. The first to file status also reflects Perrigo's continued focus on being first to market with new products. As always, Perrigo is committed to making quality healthcare more affordable for our cu
'/>"/>

SOURCE Perrigo Company
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Perrigo Announces Approval for Over-the-Counter Childrens Cetirizine Oral Solution
2. Perrigo and Partner Cobrek Confirms Filing for Generic Version of Evoclin(R) and Announcement of Lawsuit by Stiefel
3. Perrigo Announces FDA Final Approval for Polyethylene Glycol 3350
4. Perrigo Confirms Filing for Generic Version of Mens Rogaine(R) Foam
5. Perrigo Company Will Release First Quarter Fiscal 2010 Results on November 2, 2009
6. Perrigo Company Announces Dividend Increase
7. Perrigo Company Announces Quarterly Dividend
8. Perrigo Company Will Release Second Quarter Fiscal 2010 Results on February 2, 2010
9. Perrigo Company to Present at the 28th Annual J.P. Morgan Healthcare Conference
10. Perrigo Company To Present at the Sidoti Emerging Growth Conference
11. Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... -- Ameritox, the nation,s leader in pain medication monitoring, ... become part of its Urine Drug Monitoring (UDM) ... improve the clinical outcomes for injured workers. ... in the workers, compensation industry, has used UDM ... strategy for several years. By establishing a comprehensive ...
(Date:5/23/2013)... FREDERICK, Md. , May 23, 2013  BioElectronics ... safe consumer medical devices, comments on the FDA panel ... Public Advisory Panel Reclassification – Pulsed Shortwave Therapy Meeting ... Gaithersburg, MD , USA.  The focus of the ... instructed the panel to focus solely on the application ...
(Date:5/23/2013)... , May 23, 2013  CAS Medical Systems, Inc. ... devices for non-invasive patient monitoring, today announced that ... will present at the 2 nd Annual Marcum MicroCap ... Hotel in New York City . ... ET in the Estate 10 room and will be available ...
Breaking Medicine Technology:Ameritox Joins with Progressive Medical in Urine Drug Monitoring Network to Help Improve Care of Injured Workers 2Ameritox Joins with Progressive Medical in Urine Drug Monitoring Network to Help Improve Care of Injured Workers 3BioElectronics and Pulsed Shortwave Therapy Make Progress 2CASMED to Present at the 2nd Annual Marcum MicroCap Conference 2
... June 2 Jazz,Pharmaceuticals, Inc. (Nasdaq: JAZZ ) ... Phase III pivotal clinical trials of JZP-6,(sodium oxybate) for ... this trial is a key milestone in the JZP-6,program. ... trial in the fourth,quarter of 2008," said Samuel Saks, ...
... EMERYVILLE, Calif., June 2 ,Bayer HealthCare Pharmaceuticals, Inc. ... announced the presentation of new clinical data from,the ... Nexavar(R),(sorafenib) tablets in multiple tumor types including lung, ... in more than 40,countries for the treatment of ...
Cached Medicine Technology:Jazz Pharmaceuticals, Inc. Completes Enrollment in First of Two Phase III Clinical Trials of Sodium Oxybate to Treat Fibromyalgia 2Jazz Pharmaceuticals, Inc. Completes Enrollment in First of Two Phase III Clinical Trials of Sodium Oxybate to Treat Fibromyalgia 3New Nexavar Data Presented in Multiple Tumor Types at 44th American Society of Clinical Oncology Annual Meeting 2New Nexavar Data Presented in Multiple Tumor Types at 44th American Society of Clinical Oncology Annual Meeting 3New Nexavar Data Presented in Multiple Tumor Types at 44th American Society of Clinical Oncology Annual Meeting 4New Nexavar Data Presented in Multiple Tumor Types at 44th American Society of Clinical Oncology Annual Meeting 5New Nexavar Data Presented in Multiple Tumor Types at 44th American Society of Clinical Oncology Annual Meeting 6
(Date:5/24/2013)... Beach, Delaware (PRWEB) May 24, 2013 ... Mushrush has joined the Dayna Feher team at the ... Mushrush made the Delaware resorts her home in 1975. ... has since worked in all aspects of the real ... and for the past 12 years, a licensed sales ...
(Date:5/24/2013)... With Memorial Day Weekend upon us, cookout season has ... tips to help prevent grill fires throughout the spring and ... reports that gas grills led to an average of 7,100 ... grills, meanwhile, caused approximately 1,200 home fires per year during ... sharing the following tips from the NFPA to help protect ...
(Date:5/24/2013)... News) -- New research suggests a link between ... insomnia. Every additional hour someone with insomnia ... in the likelihood of moderate or high risk ... of Pennsylvania. "We were surprised by ... and suicide risk," study author, Linden Oliver, clinical ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 CHI-California ... Appropriators and the California congressional delegation, joined by ... sequestered industry user fees paid to the U.S. ... ensure that future across-the-board cuts will not include ... the FY14 Agriculture, Rural Development and FDA Appropriations ...
(Date:5/24/2013)... -- Drugs commonly used to treat glaucoma may cause ... with vision, according to a new study. The ... to reduce eye pressure, have already been shown to ... the researchers said, suggesting that the new findings could ... should be conservative when prescribing these drugs, the researchers ...
Breaking Medicine News(10 mins):Health News:Tammy Mushrush Joins ResortQuest Real Estate® and the Dayna Feher Team 2Health News:Don’t Get Burned: Five Grilling Tips from Amica Insurance 2Health News:Sleep Duration Linked to Suicidal Thoughts in People With Insomnia 2Health News:California Biomedical Industry Leaders Urge Congress to Take Action on FDA User Fees for FY2014 2Health News:California Biomedical Industry Leaders Urge Congress to Take Action on FDA User Fees for FY2014 3Health News:Common Glaucoma Drug May Cause Droopy Eyelids, Study Finds 2
... /CTL/ -- CareToLive, a not for,profit corporation, received a ... its fight against the FDA on behalf of terminal ... an,appeal in the 6th Circuit Court in Ohio., ... outside of,their grasp," said CareToLive spokesperson, Melody Davis. "Congress ...
... N.J., Nov. 26 Quest Diagnostics,Incorporated (NYSE: ... information and services, announced that it is scheduled ... Conference at the Merrill,Lynch Headquarters in New York ... presentation is scheduled to begin at 10:15 a.m. ...
... are not the best for them, study says , , ... third of prostate cancer patients may receive treatments that ... with urinary, bowel or sexual function, a new study ... give enough information to their doctor or because their ...
... NASDAQ: CRME TSX: COM, VANCOUVER, Nov. 26 /PRNewswire-FirstCall/ ... announced updated guidance for expected,interim results from its Phase ... to complete and disclose the interim,analysis in the fourth ... disclose the interim analysis in March 2008, with the ...
... (p. 30). Senior Writer Suzanne Smalley looks at,GOP presidential ... code, which is at once rigid (in public) and ... adult personality,can be traced back to his childhood and ... family of cops and hoods and to a Catholic ...
... dental care can even start in the womb, experts say ... of Americans is improving as people take better care of ... of the country,s most vulnerable individuals -- children. , Studies ... One federal report found that decay in baby teeth among ...
Cached Medicine News:Health News:CareToLive Reports: The FDA Fiddles While 30,000 Men Burn 2Health News:CareToLive Reports: The FDA Fiddles While 30,000 Men Burn 3Health News:Quest Diagnostics to Speak at the Merrill Lynch Health Services Investor Conference 2Health News:Prostate Cancer Treatments Often Compound Existing Health Problems 2Health News:Prostate Cancer Treatments Often Compound Existing Health Problems 3Health News:Prostate Cancer Treatments Often Compound Existing Health Problems 4Health News:Cardiome Updates Guidance 2Health News:Cardiome Updates Guidance 3Health News:Cardiome Updates Guidance 4Health News:NEWSWEEK: Media Lead Sheet/December 3, 2007 Issue (on newsstands Monday, November 26). 2Health News:NEWSWEEK: Media Lead Sheet/December 3, 2007 Issue (on newsstands Monday, November 26). 3Health News:NEWSWEEK: Media Lead Sheet/December 3, 2007 Issue (on newsstands Monday, November 26). 4Health News:Tooth Decay Is Kids' Stuff 2Health News:Tooth Decay Is Kids' Stuff 3
... Since 1991 Intersurgical ... breathing filters, heat and ... oxygen therapy products, hand-held ... range of accessories and ...
... product line has the right product for ... and from intubated patients to patients with ... both anesthesia and critical care applications., ... protection for patients and staff members. This ...
Bacterial/Viral Filters for Anesthesia and Respiratory Applications...
Ballard trach care HMES and filters, universal use, "Y" filter, CO 2 sampling port...
Medicine Products: